Semaglutide vs Tirzepatide

Community comparisons of semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) — switching, stacking, and head-to-head GLP-1 experiences.

3 anonymous reports

We're collecting more reports on this topic.

Submit yours

Community Q&A

What is the difference between semaglutide and tirzepatide?
Semaglutide activates GLP-1 receptors only. Tirzepatide adds GIP receptor activation — a dual mechanism community accounts frequently describe as producing stronger weight loss with a different side effect profile. The most consistent theme in comparison confessions: tirzepatide causes less nausea for users who struggled on semaglutide, while producing greater total weight loss at equivalent dose stages.
Is tirzepatide better than semaglutide for weight loss?
Community accounts that compare both compounds favour tirzepatide for total weight loss, with many describing a 5–10 lb advantage over the same timeline. A subset of reports describe better tolerability on semaglutide, particularly those sensitive to GIP-related side effects. Both produce meaningful results — the switching accounts lean tirzepatide, but the tolerability accounts are split.
What happens when you switch from semaglutide to tirzepatide?
Switching accounts describe a transition period of 2–4 weeks where the new drug 'takes over.' Most describe improved weight loss momentum after the switch. A recurring theme: starting tirzepatide at a lower dose than the semaglutide dose being discontinued, then escalating. Accounts that switch without a tapering period describe more side effects in the transition weeks.
Semaglutide vs Tirzepatide: Anonymous Reports — Peptide Confessions